NRx Pharmaceuticals’ (NRXP) “Buy” Rating Reiterated at D. Boral Capital
D. Boral Capital reiterated their buy rating on shares of NRx Pharmaceuticals (NASDAQ:NRXP – Free Report) in a research report released on Friday,Benzinga reports. D. Boral Capital currently has a $31.00 price objective on the stock. A number of other research firms have also recently weighed in on NRXP. BTIG Research assumed coverage on shares […]
D. Boral Capital reiterated their buy rating on shares of NRx Pharmaceuticals (NASDAQ:NRXP – Free Report) in a research report released on Friday,Benzinga reports. D. Boral Capital currently has a $31.00 price objective on the stock. A number of other research firms have also recently weighed in on NRXP. BTIG Research assumed coverage on shares […]
